Superworth

Zura Bio price to book ratio ZURA

Market value divided by the book value of the company's net assets, since 2023.

Today, Nov 2, 2026
2.1×
3-year median
2.3×
Against its 3-year history
43rd
percentile: 0 is its lowest day, 100 its highest
3-year range
0.5× to 11.0×
Peer median
4.9×

Zura Bio's price to book ratio is 2.1× as of Nov 2, 2026.

That is below its 3-year median of 2.3×, close to the middle of its last 3 years.

Over that time it ranged from 0.5× in May 2025 to 11.0× in Jun 2023.

The median for 4 biotech stocks of a similar size is 4.9×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.1×1.5×5.6×
20252.8×0.5×2.8×
20241.1×1.0×6.3×
20233.2×2.7×11.0×

Against its peers

Companies in Biotechnology nearest Zura Bio's size, closest first, today.

CompanyPrice to book ratio
ZURAZura Bio2.1×
PLXProtalix BioTherapeutics2.9×
MGTXMeiraGTx4.2×
VCELVericel5.6×
ADMAAdma Biologics6.1×
Peer median4.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Zura Bio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.